Loading…
Immunologic indices in myelodysplastic syndromes
Immunocompetence was evaluated in 36 untreated and noninfected patients affected with myelodysplastic syndromes (MDS). T‐cell number and activity were evaluated by counts of total T‐cells and T‐lymphocyte subsets, and by measure of DNA synthesis in response to phytohemagglutinin and Concanavalin A....
Saved in:
Published in: | Cancer 1988-03, Vol.61 (6), p.1075-1081 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 1081 |
container_issue | 6 |
container_start_page | 1075 |
container_title | Cancer |
container_volume | 61 |
creator | Colombat, Philippe H. Renoux, Micheline Lamagnere, Jean‐Pierre Renoux, Gerory |
description | Immunocompetence was evaluated in 36 untreated and noninfected patients affected with myelodysplastic syndromes (MDS). T‐cell number and activity were evaluated by counts of total T‐cells and T‐lymphocyte subsets, and by measure of DNA synthesis in response to phytohemagglutinin and Concanavalin A. B‐cells were evaluated as surface immunoglobulin‐ (SIg+) bearing cells and by serum immuno‐globulin levels. Granulocyte activities were evaluated by responses to chemotaxis and to nitroblue tetrazolium test. Complement activity was measured by classic hemolytic complement assay. In addition, circulating immune complexes were detected in serum. MDS were associated with a significant decrease in the absolute numbers of total T (E‐rosetting and T3+) cells, T4+, and T8+ cells and a dramatic decrease of the responses to Concanavalin A. An impairment of either chemotaxis or of nitroblue tetrazolium (NBT) test was frequently encountered. An increase in the levels of IgG or IgA was also a frequent feature. The findings reveal that all patients with a high degree of T‐cell impairment have refractory anemia associated with an excess of medullary blast cells. All in all, the data suggest that the counts of the absolute number of cells bearing the T3 and T8 phenotypes could be of prognostic value: the higher the number, the better the patient's survival. |
doi_str_mv | 10.1002/1097-0142(19880315)61:6<1075::AID-CNCR2820610604>3.0.CO;2-E |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_78116587</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78116587</sourcerecordid><originalsourceid>FETCH-LOGICAL-p1484-c33e2cc70b98745f19c656daa5c151a07c661b046f7636244d67fba2364fee303</originalsourceid><addsrcrecordid>eNpdkN1Kw0AQRhdRaq0-gtAr0YvUmf1NqgglVi0UC6Lg3ZBuNhJJmpptkby9Ka0FvfoYzjcDcxiLEQYIwK8RIhMASn6JURiCQHWlcahvEYwaDkeT-yB-jl94yEEjaJB3YgCDeHbDg_EB6-63D1kXAMJASfF-zE68_2xHw5XosI7gyhiIugwmZbleVEX1kdt-vkhz63yb_bJxRZU2flkkftUi3yzSuiqdP2VHWVJ4d7bLHnt7GL_GT8F09jiJR9NgiTKUgRXCcWsNzKPQSJVhZLXSaZIoiwoTMFZrnIPUmdFCcylTbbJ5woWWmXMCRI9dbO8u6-pr7fyKytxbVxTJwlVrTyZE1Co0bfF8V1zPS5fSss7LpG5o92LLsy3_zgvX7DECbWTTRhdtdNGvbNJImjayqXVNf12TIKB4RpzG_4j4AZq1d7g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78116587</pqid></control><display><type>article</type><title>Immunologic indices in myelodysplastic syndromes</title><source>EZB Electronic Journals Library</source><creator>Colombat, Philippe H. ; Renoux, Micheline ; Lamagnere, Jean‐Pierre ; Renoux, Gerory</creator><creatorcontrib>Colombat, Philippe H. ; Renoux, Micheline ; Lamagnere, Jean‐Pierre ; Renoux, Gerory</creatorcontrib><description>Immunocompetence was evaluated in 36 untreated and noninfected patients affected with myelodysplastic syndromes (MDS). T‐cell number and activity were evaluated by counts of total T‐cells and T‐lymphocyte subsets, and by measure of DNA synthesis in response to phytohemagglutinin and Concanavalin A. B‐cells were evaluated as surface immunoglobulin‐ (SIg+) bearing cells and by serum immuno‐globulin levels. Granulocyte activities were evaluated by responses to chemotaxis and to nitroblue tetrazolium test. Complement activity was measured by classic hemolytic complement assay. In addition, circulating immune complexes were detected in serum. MDS were associated with a significant decrease in the absolute numbers of total T (E‐rosetting and T3+) cells, T4+, and T8+ cells and a dramatic decrease of the responses to Concanavalin A. An impairment of either chemotaxis or of nitroblue tetrazolium (NBT) test was frequently encountered. An increase in the levels of IgG or IgA was also a frequent feature. The findings reveal that all patients with a high degree of T‐cell impairment have refractory anemia associated with an excess of medullary blast cells. All in all, the data suggest that the counts of the absolute number of cells bearing the T3 and T8 phenotypes could be of prognostic value: the higher the number, the better the patient's survival.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/1097-0142(19880315)61:6<1075::AID-CNCR2820610604>3.0.CO;2-E</identifier><identifier>PMID: 3257709</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Anemia, Refractory, with Excess of Blasts - immunology ; Anemia, Sideroblastic - immunology ; Female ; Humans ; Immunoglobulin A - analysis ; Immunoglobulin G - analysis ; Immunoglobulin M - analysis ; Leukemia, Myeloid - immunology ; Leukocyte Count ; Lymphocyte Activation - drug effects ; Male ; Middle Aged ; Myelodysplastic Syndromes - immunology ; Prognosis ; Receptors, Antigen, B-Cell - analysis ; T-Lymphocytes - classification ; T-Lymphocytes - immunology</subject><ispartof>Cancer, 1988-03, Vol.61 (6), p.1075-1081</ispartof><rights>Copyright © 1988 American Cancer Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3257709$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Colombat, Philippe H.</creatorcontrib><creatorcontrib>Renoux, Micheline</creatorcontrib><creatorcontrib>Lamagnere, Jean‐Pierre</creatorcontrib><creatorcontrib>Renoux, Gerory</creatorcontrib><title>Immunologic indices in myelodysplastic syndromes</title><title>Cancer</title><addtitle>Cancer</addtitle><description>Immunocompetence was evaluated in 36 untreated and noninfected patients affected with myelodysplastic syndromes (MDS). T‐cell number and activity were evaluated by counts of total T‐cells and T‐lymphocyte subsets, and by measure of DNA synthesis in response to phytohemagglutinin and Concanavalin A. B‐cells were evaluated as surface immunoglobulin‐ (SIg+) bearing cells and by serum immuno‐globulin levels. Granulocyte activities were evaluated by responses to chemotaxis and to nitroblue tetrazolium test. Complement activity was measured by classic hemolytic complement assay. In addition, circulating immune complexes were detected in serum. MDS were associated with a significant decrease in the absolute numbers of total T (E‐rosetting and T3+) cells, T4+, and T8+ cells and a dramatic decrease of the responses to Concanavalin A. An impairment of either chemotaxis or of nitroblue tetrazolium (NBT) test was frequently encountered. An increase in the levels of IgG or IgA was also a frequent feature. The findings reveal that all patients with a high degree of T‐cell impairment have refractory anemia associated with an excess of medullary blast cells. All in all, the data suggest that the counts of the absolute number of cells bearing the T3 and T8 phenotypes could be of prognostic value: the higher the number, the better the patient's survival.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anemia, Refractory, with Excess of Blasts - immunology</subject><subject>Anemia, Sideroblastic - immunology</subject><subject>Female</subject><subject>Humans</subject><subject>Immunoglobulin A - analysis</subject><subject>Immunoglobulin G - analysis</subject><subject>Immunoglobulin M - analysis</subject><subject>Leukemia, Myeloid - immunology</subject><subject>Leukocyte Count</subject><subject>Lymphocyte Activation - drug effects</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Myelodysplastic Syndromes - immunology</subject><subject>Prognosis</subject><subject>Receptors, Antigen, B-Cell - analysis</subject><subject>T-Lymphocytes - classification</subject><subject>T-Lymphocytes - immunology</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><recordid>eNpdkN1Kw0AQRhdRaq0-gtAr0YvUmf1NqgglVi0UC6Lg3ZBuNhJJmpptkby9Ka0FvfoYzjcDcxiLEQYIwK8RIhMASn6JURiCQHWlcahvEYwaDkeT-yB-jl94yEEjaJB3YgCDeHbDg_EB6-63D1kXAMJASfF-zE68_2xHw5XosI7gyhiIugwmZbleVEX1kdt-vkhz63yb_bJxRZU2flkkftUi3yzSuiqdP2VHWVJ4d7bLHnt7GL_GT8F09jiJR9NgiTKUgRXCcWsNzKPQSJVhZLXSaZIoiwoTMFZrnIPUmdFCcylTbbJ5woWWmXMCRI9dbO8u6-pr7fyKytxbVxTJwlVrTyZE1Co0bfF8V1zPS5fSss7LpG5o92LLsy3_zgvX7DECbWTTRhdtdNGvbNJImjayqXVNf12TIKB4RpzG_4j4AZq1d7g</recordid><startdate>19880315</startdate><enddate>19880315</enddate><creator>Colombat, Philippe H.</creator><creator>Renoux, Micheline</creator><creator>Lamagnere, Jean‐Pierre</creator><creator>Renoux, Gerory</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19880315</creationdate><title>Immunologic indices in myelodysplastic syndromes</title><author>Colombat, Philippe H. ; Renoux, Micheline ; Lamagnere, Jean‐Pierre ; Renoux, Gerory</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p1484-c33e2cc70b98745f19c656daa5c151a07c661b046f7636244d67fba2364fee303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anemia, Refractory, with Excess of Blasts - immunology</topic><topic>Anemia, Sideroblastic - immunology</topic><topic>Female</topic><topic>Humans</topic><topic>Immunoglobulin A - analysis</topic><topic>Immunoglobulin G - analysis</topic><topic>Immunoglobulin M - analysis</topic><topic>Leukemia, Myeloid - immunology</topic><topic>Leukocyte Count</topic><topic>Lymphocyte Activation - drug effects</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Myelodysplastic Syndromes - immunology</topic><topic>Prognosis</topic><topic>Receptors, Antigen, B-Cell - analysis</topic><topic>T-Lymphocytes - classification</topic><topic>T-Lymphocytes - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Colombat, Philippe H.</creatorcontrib><creatorcontrib>Renoux, Micheline</creatorcontrib><creatorcontrib>Lamagnere, Jean‐Pierre</creatorcontrib><creatorcontrib>Renoux, Gerory</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Colombat, Philippe H.</au><au>Renoux, Micheline</au><au>Lamagnere, Jean‐Pierre</au><au>Renoux, Gerory</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunologic indices in myelodysplastic syndromes</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>1988-03-15</date><risdate>1988</risdate><volume>61</volume><issue>6</issue><spage>1075</spage><epage>1081</epage><pages>1075-1081</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>Immunocompetence was evaluated in 36 untreated and noninfected patients affected with myelodysplastic syndromes (MDS). T‐cell number and activity were evaluated by counts of total T‐cells and T‐lymphocyte subsets, and by measure of DNA synthesis in response to phytohemagglutinin and Concanavalin A. B‐cells were evaluated as surface immunoglobulin‐ (SIg+) bearing cells and by serum immuno‐globulin levels. Granulocyte activities were evaluated by responses to chemotaxis and to nitroblue tetrazolium test. Complement activity was measured by classic hemolytic complement assay. In addition, circulating immune complexes were detected in serum. MDS were associated with a significant decrease in the absolute numbers of total T (E‐rosetting and T3+) cells, T4+, and T8+ cells and a dramatic decrease of the responses to Concanavalin A. An impairment of either chemotaxis or of nitroblue tetrazolium (NBT) test was frequently encountered. An increase in the levels of IgG or IgA was also a frequent feature. The findings reveal that all patients with a high degree of T‐cell impairment have refractory anemia associated with an excess of medullary blast cells. All in all, the data suggest that the counts of the absolute number of cells bearing the T3 and T8 phenotypes could be of prognostic value: the higher the number, the better the patient's survival.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>3257709</pmid><doi>10.1002/1097-0142(19880315)61:6<1075::AID-CNCR2820610604>3.0.CO;2-E</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-543X |
ispartof | Cancer, 1988-03, Vol.61 (6), p.1075-1081 |
issn | 0008-543X 1097-0142 |
language | eng |
recordid | cdi_proquest_miscellaneous_78116587 |
source | EZB Electronic Journals Library |
subjects | Adult Aged Aged, 80 and over Anemia, Refractory, with Excess of Blasts - immunology Anemia, Sideroblastic - immunology Female Humans Immunoglobulin A - analysis Immunoglobulin G - analysis Immunoglobulin M - analysis Leukemia, Myeloid - immunology Leukocyte Count Lymphocyte Activation - drug effects Male Middle Aged Myelodysplastic Syndromes - immunology Prognosis Receptors, Antigen, B-Cell - analysis T-Lymphocytes - classification T-Lymphocytes - immunology |
title | Immunologic indices in myelodysplastic syndromes |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T07%3A04%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunologic%20indices%20in%20myelodysplastic%20syndromes&rft.jtitle=Cancer&rft.au=Colombat,%20Philippe%20H.&rft.date=1988-03-15&rft.volume=61&rft.issue=6&rft.spage=1075&rft.epage=1081&rft.pages=1075-1081&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/1097-0142(19880315)61:6%3C1075::AID-CNCR2820610604%3E3.0.CO;2-E&rft_dat=%3Cproquest_pubme%3E78116587%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p1484-c33e2cc70b98745f19c656daa5c151a07c661b046f7636244d67fba2364fee303%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78116587&rft_id=info:pmid/3257709&rfr_iscdi=true |